Disease ID | Disease name | Source of annotation with GNAS | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
166350 | OSSEOUS HETEROPLASIA, PROGRESSIVE | OMIM, HUMSAVAR | link to OMIM | 1 | GNAS |
103580 | PSEUDOHYPOPARATHYROIDISM, TYPE IA | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | GNAS |
612463 | PSEUDOPSEUDOHYPOPARATHYROIDISM | ClinVar, OMIM | link to OMIM | 1 | GNAS |
612462 | PSEUDOHYPOPARATHYROIDISM, TYPE IC | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | GNAS |
174800 | MCCUNE-ALBRIGHT SYNDROME | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | GNAS |
603233 | PSEUDOHYPOPARATHYROIDISM, TYPE IB | ClinVar, OMIM | link to OMIM | 3 | STX16, GNAS, GNAS-AS1 |
219090 | PITUITARY ADENOMA, ACTH-SECRETING | ClinVar | link to OMIM | 4 | USP8, AIP, GNAS, GNAI2 |
219080 | ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | GNAS |
102200 | PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1 | ClinVar, OMIM | link to OMIM | 2 | GNAS, AIP |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Platelet activation | hsa04611 | 5.66 |
Calcium signaling pathway | hsa04020 | 5.22 |
Estrogen signaling pathway | hsa04915 | 6.11 |
cAMP signaling pathway | hsa04024 | 5.05 |
Taste transduction | hsa04742 | 6.99 |
Serotonergic synapse | hsa04726 | 5.84 |
Dopaminergic synapse | hsa04728 | 5.69 |
Dilated cardiomyopathy | hsa05414 | 6.08 |
Oxytocin signaling pathway | hsa04921 | 5.4 |
Vasopressin-regulated water reabsorption | hsa04962 | 7.18 |
Endocrine and other factor-regulated calcium reabsorption | hsa04961 | 7.12 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
Amoebiasis | hsa05146 | 5.82 |
Vascular smooth muscle contraction | hsa04270 | 5.74 |
Gap junction | hsa04540 | 6.24 |
Pathways in cancer | hsa05200 | 3.98 |
GnRH signaling pathway | hsa04912 | 6.18 |
Ovarian steroidogenesis | hsa04913 | 7.07 |
Rap1 signaling pathway | hsa04015 | 4.97 |
Insulin secretion | hsa04911 | 6.18 |
Melanogenesis | hsa04916 | 5.97 |
Vibrio cholerae infection | hsa05110 | 6.86 |
Thyroid hormone synthesis | hsa04918 | 6.56 |
Circadian entrainment | hsa04713 | 6.11 |
Long-term depression | hsa04730 | 6.74 |
Salivary secretion | hsa04970 | 6.23 |
Gastric acid secretion | hsa04971 | 6.48 |
Pancreatic secretion | hsa04972 | 6.07 |
Bile secretion | hsa04976 | 6.56 |
Morphine addiction | hsa05032 | 6.15 |
Cocaine addiction | hsa05030 | 7.07 |
Amphetamine addiction | hsa05031 | 6.62 |
Alcoholism | hsa05034 | 5.59 |
Inflammatory mediator regulation of TRP channels | hsa04750 | 6.07 |
Adrenergic signaling in cardiomyocytes | hsa04261 | 5.44 |
Glutamatergic synapse | hsa04724 | 5.84 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
G alpha (i) signalling events | R-HSA-418594 | 5.1 |
G alpha (z) signalling events | R-HSA-418597 | 7.46 |
Transmembrane transport of small molecules | R-HSA-382551 | 3.79 |
Metabolism | R-HSA-1430728 | 2.34 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.59 |
Signaling by Hedgehog | R-HSA-5358351 | 5.79 |
Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.56 |
G alpha (s) signalling events | R-HSA-418555 | 5.99 |
Hedgehog 'off' state | R-HSA-5610787 | 6.19 |
PKA activation in glucagon signalling | R-HSA-164378 | 8.89 |
Platelet homeostasis | R-HSA-418346 | 6.68 |
GPCR ligand binding | R-HSA-500792 | 4.19 |
Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.73 |
GPCR downstream signaling | R-HSA-388396 | 3.07 |
Integration of energy metabolism | R-HSA-163685 | 6.24 |
Aquaporin-mediated transport | R-HSA-445717 | 7.31 |
Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.94 |
Class B/2 (Secretin family receptors) | R-HSA-373080 | 6.52 |
Regulation of insulin secretion | R-HSA-422356 | 6.66 |
Glucagon-type ligand receptors | R-HSA-420092 | 8.08 |
Signaling by GPCR | R-HSA-372790 | 2.68 |
Hemostasis | R-HSA-109582 | 3.98 |
Signal Transduction | R-HSA-162582 | 1.78 |
GO term | GO ID | GO IC |
---|---|---|
adrenergic receptor binding | GO:0031690 | 6.85 |
purine ribonucleoside triphosphate binding | GO:0035639 | 2.22 |
mu-type opioid receptor binding | GO:0031852 | 8.35 |
beta-2 adrenergic receptor binding | GO:0031698 | 8.13 |
macromolecular complex binding | GO:0044877 | 2.61 |
binding | GO:0005488 | 0.18 |
signal transducer activity | GO:0004871 | 2.28 |
G-protein coupled receptor binding | GO:0001664 | 4.18 |
nucleotide binding | GO:0000166 | 1.96 |
heterocyclic compound binding | GO:1901363 | 1.06 |
purine nucleoside binding | GO:0001883 | 2.22 |
nucleoside binding | GO:0001882 | 2.21 |
cation binding | GO:0043169 | 1.4 |
pyrophosphatase activity | GO:0016462 | 3.04 |
ion binding | GO:0043167 | 1.36 |
guanyl ribonucleotide binding | GO:0032561 | 3.73 |
corticotropin-releasing hormone receptor 1 binding | GO:0051430 | 8.35 |
nucleoside phosphate binding | GO:1901265 | 1.96 |
ribonucleoside binding | GO:0032549 | 2.22 |
protein complex binding | GO:0032403 | 3.09 |
purine nucleotide binding | GO:0017076 | 2.19 |
metal ion binding | GO:0046872 | 1.41 |
GTP binding | GO:0005525 | 3.78 |
hydrolase activity | GO:0016787 | 1.9 |
G-protein beta/gamma-subunit complex binding | GO:0031683 | 6.65 |
D1 dopamine receptor binding | GO:0031748 | 7.66 |
insulin-like growth factor receptor binding | GO:0005159 | 7.03 |
GTPase activity | GO:0003924 | 4.31 |
nucleoside-triphosphatase activity | GO:0017111 | 3.09 |
ionotropic glutamate receptor binding | GO:0035255 | 6.56 |
glutamate receptor binding | GO:0035254 | 6.13 |
small molecule binding | GO:0036094 | 1.89 |
catalytic activity | GO:0003824 | 1.05 |
peptide hormone receptor binding | GO:0051428 | 6.91 |
corticotropin-releasing hormone receptor binding | GO:0051429 | 7.95 |
neuropeptide receptor binding | GO:0071855 | 6.37 |
hormone receptor binding | GO:0051427 | 4.57 |
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GO:0016818 | 3.03 |
carbohydrate derivative binding | GO:0097367 | 2.03 |
organic cyclic compound binding | GO:0097159 | 1.05 |
hydrolase activity, acting on acid anhydrides | GO:0016817 | 3.03 |
opioid receptor binding | GO:0031628 | 7.54 |
guanyl nucleotide binding | GO:0019001 | 3.73 |
protein binding | GO:0005515 | 0.46 |
purine ribonucleotide binding | GO:0032555 | 2.2 |
dopamine receptor binding | GO:0050780 | 6.85 |
receptor binding | GO:0005102 | 2.43 |
purine ribonucleoside binding | GO:0032550 | 2.22 |
ribonucleotide binding | GO:0032553 | 2.19 |